No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - General
Yung Zip Chemical Ind. Co., Ltd. is a global provider specializing in the manufacture of essential pharmaceutical components. The company supplies active pharmaceutical ingredients (APIs), their intermediate precursors, and various specialty chemicals to markets around the world. Their diverse product portfolio includes a wide array of therapeutic agents addressing conditions such as hypertension, iron overload, inflammation, pain, fever, fungal infections, schizophrenia, blood clotting issues, genital herpes outbreaks, and sleep disorders (hypnotics and sedatives). In addition to these core offerings, Yung Zip also provides pharmaceutical excipients, such as sodium starch glycolate, and offers bespoke research, development, and manufacturing services. The company, established in 1978, is headquartered in Taichung, Taiwan.
www.yungzip.comNo one on the platform currently holds 4102.TWO.
No tracked institution reports a position in 4102.TWO as of their last filing.
No one on the platform has traded 4102.TWO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -18.8% | 0.5% | ||||
| Profit Margin % | -3.0% | 6.6% | ||||
| Free Cash Flow Margin % | -7.7% | 8.0% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $437M | -4.0% | $0.97 | $0.97–$0.97 | — | 1 |
| 2027 | $459M | +5.0% | $0.87 | $0.87–$0.87 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4102.TWOYung Zip Chemical Ind. Co., Ltd. | $18.95 | +0.80% | $803M | — |
| 4117.TWOGeneral Biologicals Corporation | $8.92 | -0.56% | $627M | — |
| 4188.TWOAmCad BioMed Corporation | $14.15 | -0.35% | $896M | — |
| 4192.TWOSynCore Biotechnology Co.,Ltd | $19.45 | +3.18% | $684M | — |
| 4732.TWONatureWise Biotech & Medicals Corporation | $18.00 | +0.56% | $869M | — |
| 6483.TWOOriginal BioMedicals Co., Ltd. | $13.25 | +5.16% |
Source: Financial Modeling Prep · peers by sector/industry
| $885M |
| — |
| 6493.TWOTtbio Corp. | $37.00 | +0.00% | $1.1B | — |